Elective percutaneous intervention for unprotected left main coronary artery stenosis complicated with left anterior

Gui-Tang Yang1, Ya-Ling Han, Quan-Min Jing

  • 1Department of Cardiology, Shenyang Northern Hospital, Shenyang, Liaoning 110840, China.

Insights

Percutaneous coronary intervention is a safe option for high-risk patients with unprotected left main coronary artery (ULMCA) stenosis and left anterior descending (LAD) chronic total occlusion (CTO). This approach offers feasible treatment for inoperable patients, demonstrating good long-term outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Patients with unprotected left main coronary artery (ULMCA) stenosis and left anterior descending (LAD) chronic total occlusion (CTO) often require bypass surgery.
  • However, some patients are inoperable or high-risk surgical candidates.

Purpose of the Study:

  • To explore treatment strategies for ULMCA stenosis complicated by LAD CTO.
  • To evaluate the efficacy of percutaneous coronary intervention (PCI) in these high-risk patients.

Main Methods:

  • Retrospective analysis of 78 patients with ULMCA stenosis and LAD CTO treated with stenting from 2001 to 2009.
  • Patients were either young (<40 years) refusing surgery or unsuitable for surgery (e.g., advanced age, comorbidities, high EuroSCORE).
  • Four distinct PCI strategies were employed based on lesion characteristics.

Main Results:

  • High procedural success rate (94.9%) with no deaths or thromboses.
  • In-hospital non-Q-wave myocardial infarction occurred in 6.4% of patients.
  • Long-term follow-up (52 months) showed 3.8% cardiac deaths and 5.1% nonfatal myocardial infarctions. Major adverse cardiac events occurred in 16.7%.

Conclusions:

  • Percutaneous intervention is a safe and feasible strategy for selected high-risk patients with ULMCA and LAD CTO.
  • Individualized therapeutic strategies are key to successful PCI outcomes in this complex patient group.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...